En esta página
01TARS precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
TARS Tarsus Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$73,00
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$53,89mínimo 52 semanas
$91,53máximo 52 semanas
Capitalización Bursátil (MRQ)
$3.16B
P/E (TTM)
-68.9
BPA (TTM)
$-1.06
Ingresos (TTM)
$606M
tus insignias
Rango 52S
$54–$92
Calificación del Analista
STRONG BUY
Precio Objetivo
$100
P/E
-68.9
ROE
-13.7%
Margen de Beneficio Neto
-7.7%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
TARS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$73.00
Capitalización Bursátil (MRQ)
$3.16B
P/E (TTM)
-68.9
BPA (TTM)
$-1.06
Ingresos (TTM)
$606M
ROE (TTM)
-13.7%
Deuda/Capital (MRQ)
0.2
Rango 52S
$54–$92
TARS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$451M2020-12-31 → 2025-12-31
BPA$-1.592020-12-31 → 2025-12-31
Flujo de caja libre$-22M2020-12-31 → 2025-12-31
Margen neto-7.7%2021-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | TARS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -68.9promedio 5A ≈-22.7 | ≈-22.7 | · | · | |
| P/S (TTM) | 5.2promedio 5A ≈16.5 | ≈16.5 | · | · | |
| P/C (MRQ) | 9.1promedio 5A ≈5.6 | ≈5.6 | 6.5 | Sobrevalorado | |
| EV / EBITDA | -39.4promedio 5A ≈-16.6 | ≈-16.6 | · | · | |
| Precio / FCF (TTM) | 56.4promedio 5A ≈-9.5 | ≈-9.5 | · | · | |
| Precio / Flujo de Caja (TTM) | 42.6promedio 5A ≈-39.0 | ≈-39.0 | · | · | |
| EV / Ingresos (TTM) | 4.6promedio 5A ≈13.3 | ≈13.3 | · | · | |
| EV / FCF (TTM) | 49.7promedio 5A ≈-42.8 | ≈-42.8 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 9.3promedio 5A ≈5.7 | ≈5.7 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | TARS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -8.0%promedio 5A ≈-233.3% | ≈-233.3% | 2.4% | Débil | |
| EBITDA Margin (Margen EBITDA) | -15.7%promedio 5A ≈-233.3% | ≈-233.3% | 2.6% | Débil | |
| Pretax Margin (Margen antes de impuestos) | -14.3%promedio 5A ≈-224.2% | ≈-224.2% | 10.3% | Débil | |
| Margen de Beneficio Neto (TTM) | -7.7%promedio 5A ≈-224.3% | ≈-224.3% | 7.1% | Débil | |
| ROA (TTM) | -8.4%promedio 5A ≈-28.7% | ≈-28.7% | -7.0% | Débil | |
| ROE (TTM) | -13.7%promedio 5A ≈-35.0% | ≈-35.0% | -20.8% | En línea | |
| ROIC | -17.6%promedio 5A ≈-31.7% | ≈-31.7% | -11.7% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | TARS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 0.2promedio 5A ≈0.2 | ≈0.2 | 1.4 | Baja deuda | |
| Ratio corriente (MRQ) | 3.2promedio 5A ≈9.0 | ≈9.0 | 2.7 | Liquidez sólida | |
| Ratio Rápido (MRQ) | 3.1promedio 5A ≈8.7 | ≈8.7 | 1.8 | Liquidez sólida | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 0.2promedio 5A ≈0.2 | ≈0.2 | 1.4 | Baja deuda |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | TARS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 146.7%promedio 5A ≈252.0% | ≈252.0% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | 159.5% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | TARS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 1.0promedio 5A ≈0.4 | ≈0.4 | 0.8 | De primer nivel | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 6.8promedio 5A ≈4.9 | ≈4.9 | 4.6 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$1.2M | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-25.2%
Próximo informe
Nov 02, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 4, 2026 | $-0.43 | $-0.20 | -115.1% |
| 31 de marzo de 2026 | May 12, 2026 | $-0.16 | $-0.38 | 57.6% |
| 31 de diciembre de 2025 | $-0.20 | $-0.10 | -106.2% | |
| 30 de septiembre de 2025 | $-0.30 | $-0.36 | 16.1% | |
| 30 de junio de 2025 | $-0.48 | $-0.41 | -17.8% | |
| 31 de marzo de 2025 | $-0.64 | $-0.75 | 14.1% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $451M | $183M | $17M | $26M | $57M | $0 | |
| R&D Expense | $64M | $53M | $50M | $43M | $42M | $19M | |
| SG&A Expense | $427M | $237M | $109M | $45M | $25M | $8M | |
| Operating Expenses | $522M | $304M | $161M | $89M | $69M | $27M | |
| Operating Income | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M | |
| Interest Expense | · | · | $3M | $2M | $0 | · | |
| Other Non-op | $-202.0K | $-206.0K | $274.0K | $86.0K | $-73.0K | $0 | |
| Pretax Income | $-64M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Income Tax | $2M | $0 | $0 | $-4.0K | $55.0K | $1.0K | |
| Net Income | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| EPS (Basic) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| EPS (Diluted) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| Shares (Basic) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| Shares (Diluted) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| EBITDA | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $184M | $95M | $225M | $72M | $171M | $168M | |
| Short-term Investments | $234M | $197M | $2M | $145M | $483.0K | $0 | |
| Receivables | $85M | $47M | $17M | $0 | $0 | $0 | |
| Inventory | $4M | $3M | $3M | $0 | · | · | |
| Prepaid Expense | $13M | $15M | $8M | $5M | $4M | $2M | |
| Current Assets | $523M | $357M | $256M | $225M | $176M | $171M | |
| PP&E (Net) | $12M | $2M | $1M | $957.0K | $755.0K | $548.0K | |
| PP&E (Gross) | $14M | $4M | $3M | $2M | $976.0K | $682.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $546.0K | $221.0K | $134.0K | |
| Intangibles | $7M | $8M | $4M | $0 | · | · | |
| Other Non-current Assets | $2M | $999.0K | $2M | $585.0K | $1M | $81.0K | |
| Total Assets | $562M | $377M | $265M | $228M | $179M | $172M | |
| Accounts Payable | $16M | $9M | · | · | · | · | |
| Current Liabilities | $136M | $81M | $37M | $15M | $11M | $5M | |
| Capital Leases | $11M | $0 | $2M | $52.0K | $585.0K | $549.0K | |
| Other Non-current Liabilities | $11M | $0 | $2M | $100.0K | $699.0K | $605.0K | |
| Total Liabilities | $219M | $152M | $69M | $35M | $12M | $6M | |
| Long-term Debt | $72M | $72M | $30M | $19M | · | · | |
| Total Debt | $72M | $72M | $30M | $19M | · | · | |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | |
| Paid-in Capital | $770M | $585M | $442M | $302M | $213M | $199M | |
| Retained Earnings | $-427M | $-360M | $-245M | $-109M | $-47M | $-33M | |
| AOCI | $381.0K | $179.0K | $-2.0K | $-74.0K | $0 | · | |
| Stockholders' Equity | $343M | $225M | $197M | $193M | $167M | $166M | |
| Liabilities + Equity | $562M | $377M | $265M | $228M | $179M | $172M | |
| Shares Outstanding | 42,553,931 | 38,349,826 | 34,211,190 | 26,727,458 | 20,698,737 | 20,323,201 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $42M | $28M | $20M | $13M | $8M | $839.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $961.0K | $540.0K | $133.0K | $0 | · | · | |
| Operating Cash Flow | $-12M | $-83M | $-117M | $-49M | $4M | $-21M | |
| CapEx | $10M | $2M | $2M | $506.0K | $586.0K | $456.0K | |
| Investing Cash Flow | $-42M | $-199M | $141M | $-145M | $-586.0K | $-456.0K | |
| Debt Issued | $0 | $75M | $10M | $20M | · | · | |
| Net Debt Issued | $0 | $75M | · | · | · | · | |
| Financing Cash Flow | $143M | $155M | $130M | $94M | $21.0K | $132M | |
| Net Change in Cash | $89M | $-128M | $153M | $-100M | $3M | $110M | |
| Free Cash Flow | $-22M | $-85M | $-119M | $-50M | $3M | $-22M | |
| Levered FCF | · | · | $-122M | $-52M | · | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| Net Margin | -14.7% | -63.2% | -778.9% | -240.5% | -24.2% | · | |
| Pretax Margin | -14.3% | -63.2% | -778.9% | -240.5% | -24.1% | · | |
| EBITDA Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| ROA | -14.1% | -36.0% | -55.1% | -30.5% | -7.9% | -23.3% | |
| ROE | -19.7% | -50.0% | -66.2% | -31.4% | -8.0% | -36.2% | |
| ROIC | -17.6% | -40.7% | -63.1% | -29.5% | -7.3% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 | 31.7 | |
| Quick Ratio | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 | 31.2 | |
| Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | -42.8 | -28.5 | · | · |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.1 | 0.1 | 0.3 | · | |
| Receivables Turnover | 6.8 | 5.8 | 2.1 | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.07 | $5.85 | $5.76 | $7.22 | $8.06 | $8.17 | |
| Revenue / Share | $10.80 | $4.87 | $0.59 | $1.05 | $2.77 | · | |
| Cash Flow / Share | $-0.30 | $-2.21 | $-4.00 | $-1.99 | $0.18 | · | |
| Cash / Share | $4.32 | $2.47 | $6.58 | $2.68 | $8.28 | $8.27 | |
| Dividend / Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| EPS (TTM) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | 948.6% | -32.4% | -54.7% | · | · | |
| Revenue CAGR 3Y | 159.5% | 47.5% | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $451M | $183M | $17M | $26M | $57M | $0 | |
| Net Income TTM | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Market Cap | $3.48B | $2.12B | $693M | $392M | $466M | $840M | |
| Enterprise Value | $3.14B | $1.90B | $495M | $194M | · | · | |
| P/E | -51.5 | -18.0 | -4.4 | -5.8 | -33.6 | -9.6 | |
| P/S | 7.7 | 11.6 | 39.7 | 15.2 | 8.2 | · | |
| P/B | 10.1 | 9.5 | 3.5 | 2.0 | 2.8 | 5.1 | |
| P / Tangible Book | 10.4 | 9.8 | 3.6 | 2.0 | 2.8 | 5.1 | |
| P / Cash Flow | -279.8 | -25.6 | -5.9 | -8.0 | 124.3 | -39.7 | |
| P / FCF | -156.2 | -25.1 | -5.8 | -7.9 | 147.3 | -38.9 | |
| EV / EBITDA | -44.2 | -15.8 | -3.5 | -3.1 | · | · | |
| EV / FCF | -140.7 | -22.5 | -4.2 | -3.9 | · | · | |
| EV / Revenue | 7.0 | 10.4 | 28.4 | 7.5 | · | · | |
| Earnings Yield | -1.9% | -5.5% | -22.8% | -17.2% | -3.0% | -10.4% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $174M | $162M | $152M | $119M | $103M | $78M | $66M | $48M | $41M | $28M | $13M | $2M | $0 | $2M | $10M | $0 | |
| Cost of Revenue | $12M | $9M | · | · | $6M | $5M | · | · | · | · | · | · | $0 | $0 | · | $0 | |
| R&D Expense | $31M | $22M | $18M | $16M | $16M | $14M | $17M | $12M | $12M | $12M | $13M | $12M | $13M | $12M | $10M | $11M | |
| SG&A Expense | $151M | $136M | $131M | $109M | $103M | $85M | $69M | $58M | $59M | $52M | $43M | $30M | $20M | $15M | $15M | $12M | |
| Operating Expenses | $194M | $168M | $160M | $133M | $125M | $105M | $91M | $73M | $74M | $65M | $58M | $43M | $33M | $27M | $25M | $23M | |
| Operating Income | $-20M | $-6M | $-8M | $-15M | $-22M | $-26M | $-24M | $-25M | $-33M | $-38M | $-44M | $-41M | $-33M | $-25M | $-15M | $-23M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $983.0K | · | $858.0K | $815.0K | $684.0K | · | $633.0K | |
| Other Non-op | $-281.0K | $-87.0K | $-74.0K | $98.0K | $-145.0K | $-81.0K | $-27.0K | $67.0K | $-65.0K | $-181.0K | $363.0K | $-48.0K | $-47.0K | $6.0K | $-50.0K | $-7.0K | |
| Income Tax | $3M | $2M | · | · | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-5.0K | |
| Net Income | $-19M | $-7M | $-8M | $-13M | $-20M | $-25M | $-23M | $-23M | $-33M | $-36M | $-42M | $-39M | $-31M | $-23M | $-14M | $-23M | |
| EPS (Basic) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| EPS (Diluted) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| Shares (Basic) | 43,393,643 | 42,956,973 | · | 42,607,717 | 42,360,452 | 39,345,359 | · | 38,381,968 | 37,823,233 | 35,300,655 | · | 30,622,440 | 26,815,733 | 26,742,023 | · | 26,662,374 | |
| Shares (Diluted) | 43,393,643 | 42,956,973 | · | 42,607,717 | 42,360,452 | 39,345,359 | · | 38,381,968 | 37,823,233 | 35,300,655 | · | 30,622,440 | 26,815,733 | 26,742,023 | · | 26,662,374 | |
| EBITDA | $-20M | $-6M | · | $-15M | $-22M | $-26M | · | $-25M | $-33M | $-38M | · | $-41M | $-33M | $-25M | · | $-23M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $102M | $184M | $113M | $97M | $176M | $95M | $176M | $181M | $194M | · | $227M | $107M | $66M | · | $169M | |
| Short-term Investments | $245M | $287M | $234M | $289M | $284M | $232M | $197M | $141M | $142M | $105M | · | $20M | $71M | $135M | · | $57M | |
| Receivables | $96M | $100M | $85M | $73M | $58M | $62M | $47M | $29M | $30M | $30M | · | $5M | · | $2M | · | $17.0K | |
| Inventory | $4M | $5M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $4M | · | $15.0K | · | · | · | · | |
| Prepaid Expense | $10M | $27M | $13M | $22M | $29M | $6M | $15M | $7M | $6M | $7M | · | $6M | $5M | $5M | · | $3M | |
| Current Assets | $562M | $537M | $523M | $502M | $474M | $481M | $357M | $357M | $363M | $341M | · | $259M | $183M | $209M | · | $234M | |
| PP&E (Net) | $20M | $18M | $12M | $6M | $3M | $3M | $2M | $2M | $2M | $1M | · | $2M | $2M | $1M | · | $951.0K | |
| PP&E (Gross) | $22M | $20M | $14M | $8M | $6M | $5M | $4M | $4M | $4M | $3M | · | $3M | $2M | $2M | · | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $832.0K | $649.0K | · | $448.0K | |
| Intangibles | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $4M | $4M | · | $4M | · | · | · | · | |
| Other Non-current Assets | $660.0K | $715.0K | $2M | $1M | $1M | $616.0K | $999.0K | $888.0K | $846.0K | $1M | · | $1M | $1M | $529.0K | · | $583.0K | |
| Total Assets | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Accounts Payable | $40M | $24M | $16M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $176M | $144M | $136M | $117M | $90M | $86M | $81M | $66M | $52M | $43M | · | $23M | $15M | $13M | · | $14M | |
| Capital Leases | $16M | $16M | $11M | $10M | $0 | $0 | · | $1M | $1M | $2M | · | $2M | $2M | · | · | $169.0K | |
| Other Non-current Liabilities | $16M | $16M | $11M | $10M | · | · | $0 | $1M | $1M | $2M | · | $2M | $2M | $40.0K | · | $209.0K | |
| Total Liabilities | $264M | $232M | $219M | $199M | $162M | $158M | $152M | $139M | $125M | $74M | · | $55M | $41M | $38M | · | $34M | |
| Long-term Debt | $73M | $73M | $72M | $72M | $72M | $72M | $72M | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Total Debt | $73M | $73M | · | $72M | $72M | $72M | · | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Paid-in Capital | $799M | $783M | $770M | $753M | $738M | $728M | $585M | $574M | $566M | $556M | · | $416M | $311M | $306M | · | $298M | |
| Retained Earnings | $-452M | $-434M | $-427M | $-418M | $-406M | $-385M | $-360M | $-337M | $-314M | $-280M | · | $-203M | $-164M | $-132M | · | $-95M | |
| AOCI | $-557.0K | $-298.0K | $381.0K | $289.0K | $39.0K | $85.0K | $179.0K | $346.0K | $-176.0K | $-63.0K | · | $-8.0K | $-23.0K | $-70.0K | · | $-10.0K | |
| Stockholders' Equity | $347M | $349M | $343M | $335M | $333M | $342M | $225M | $237M | $252M | $275M | $197M | $214M | $148M | $173M | $193M | $203M | |
| Liabilities + Equity | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Shares Outstanding | 43,271,347 | 43,021,312 | 42,553,931 | 42,447,882 | 42,210,972 | 41,995,537 | 38,349,826 | 38,196,072 | 38,030,385 | 37,749,468 | 34,211,190 | 33,104,087 | 26,899,572 | 26,800,512 | 26,727,458 | 26,671,812 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $12M | $14M | $12M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Amort. of Intangibles | $200.0K | $240.0K | $321.0K | $200.0K | $200.0K | $240.0K | $240.0K | $100.0K | $100.0K | $100.0K | $133.0K | $0 | $0 | $0 | $0 | · | |
| Operating Cash Flow | $61M | $-25M | $19M | $18M | $-29M | $-21M | $-22M | $-9M | $-14M | $-38M | $-39M | $-32M | $-24M | $-22M | $-11M | $-19M | |
| CapEx | $4M | $6M | $6M | $2M | $1M | $590.0K | $72.0K | $282.0K | $1M | $174.0K | $0 | $375.0K | $787.0K | $340.0K | $127.0K | $96.0K | |
| Investing Cash Flow | $38M | $-59M | $49M | $-5M | $-52M | $-35M | $-60M | $3M | $-41M | $-102M | $18M | $47M | $64M | $11M | $-87M | $-57M | |
| Debt Issued | · | · | $0 | $0 | · | · | $0 | $0 | $75M | $0 | $0 | $5M | $0 | $5M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $5M | · | · | |
| Stock Issued | $0 | $0 | · | $0 | $-354.0K | $135M | · | $-43.0K | $-274.0K | $99M | · | $99M | $0 | $0 | · | $-218.0K | |
| Net Stock Activity | · | $0 | · | · | · | $135M | · | · | · | $99M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $1M | $2M | $3M | $2M | $137M | $3M | $639.0K | $42M | $109M | $20M | $105M | $510.0K | $5M | $264.0K | $-136.0K | |
| Net Change in Cash | $102M | $-82M | $71M | $16M | $-79M | $81M | $-79M | $-5M | $-13M | $-31M | $-2M | $120M | $41M | $-6M | $-98M | $-76M | |
| Taxes Paid | $3M | $2M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-30M | · | · | · | $-21M | · | · | · | $-38M | · | · | · | $-22M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| Net Margin | -10.7% | -4.3% | · | -10.6% | -19.8% | -32.1% | · | -48.7% | -81.6% | -129.4% | · | -2092.4% | · | · | · | · | |
| EBITDA Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| ROA | -3.4% | -1.3% | · | -2.8% | -4.7% | -5.9% | · | -7.3% | -11.8% | -12.8% | · | -15.5% | -14.2% | -11.9% | · | -10.5% | |
| ROE | -5.5% | -2.0% | · | -4.4% | -7.0% | -8.1% | · | -10.4% | -16.7% | -15.9% | · | -18.8% | -17.0% | -14.5% | · | -11.8% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | · | 4.3 | 5.3 | 5.6 | · | 5.4 | 7.0 | 8.0 | · | 11.2 | 12.4 | 15.7 | · | 16.4 | |
| Quick Ratio | 3.1 | 3.4 | · | 4.1 | 4.9 | 5.4 | · | 5.3 | 6.8 | 7.7 | · | 10.8 | 12.1 | 15.4 | · | 15.9 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -38.3 | · | -47.7 | -40.3 | -36.5 | · | -36.2 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | · | · | · | 0.0 | |
| Inventory Turnover | 2.9 | 2.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 2.3 | 2.0 | · | 2.3 | 2.3 | 1.7 | · | 2.8 | 2.8 | 1.7 | · | 0.7 | · | · | · | 0.0 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.01 | $8.11 | · | $7.89 | $7.88 | $8.15 | · | $6.22 | $6.63 | $7.29 | · | $6.45 | $5.49 | $6.47 | · | $7.60 | |
| Revenue / Share | $4.01 | $3.77 | · | $2.79 | $2.42 | $1.99 | · | $1.25 | $1.08 | $0.78 | · | $0.06 | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.57 | · | · | · | $-0.52 | · | · | · | $-1.07 | · | · | · | $-0.82 | · | · | |
| Cash / Share | $4.73 | $2.38 | · | $2.66 | $2.29 | $4.19 | · | $4.61 | $4.76 | $5.13 | · | $6.85 | $3.97 | $2.46 | · | $6.35 | |
| EPS (TTM) | $-1.06 | $-1.11 | · | $-1.99 | $-2.30 | $-2.70 | · | $-3.79 | $-4.46 | $-4.75 | · | $-3.79 | $-3.35 | $-2.42 | · | $-2.73 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $606M | $535M | · | $366M | $296M | $234M | · | $130M | $83M | $43M | · | $14M | $12M | $28M | · | $16M | |
| Net Income TTM | $-46M | $-48M | · | $-81M | $-92M | $-105M | · | $-134M | $-150M | $-148M | · | $-108M | $-91M | $-65M | · | $-63M | |
| Market Cap | $2.72B | $3.02B | · | $2.52B | $1.71B | $2.16B | · | $1.26B | $1.03B | $1.37B | · | $588M | $486M | $337M | · | $457M | |
| Enterprise Value | $2.35B | $2.70B | · | $2.19B | $1.40B | $1.82B | · | $1.01B | $782M | $1.10B | · | $371M | $332M | $160M | · | $249M | |
| P/E | -59.4 | -63.2 | · | -29.9 | -17.6 | -19.0 | · | -8.7 | -6.1 | -7.7 | · | -4.7 | -5.4 | -5.2 | · | -6.3 | |
| P/S | 4.5 | 5.6 | · | 6.9 | 5.8 | 9.2 | · | 9.7 | 12.4 | 32.2 | · | 40.9 | 38.9 | 12.1 | · | 28.3 | |
| P/B | 7.9 | 8.6 | · | 7.5 | 5.1 | 6.3 | · | 5.3 | 4.1 | 5.0 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Tangible Book | 8.0 | 8.8 | · | 7.7 | 5.3 | 6.5 | · | 5.5 | 4.2 | 5.1 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Cash Flow | · | -122.4 | · | · | · | -104.5 | · | · | · | -36.3 | · | · | · | -15.3 | · | · | |
| EV / Revenue | 3.9 | 5.0 | · | 6.0 | 4.7 | 7.8 | · | 7.8 | 9.4 | 25.9 | · | 25.8 | 26.6 | 5.8 | · | 15.4 | |
| Earnings Yield | -1.7% | -1.6% | · | -3.4% | -5.7% | -5.3% | · | -11.5% | -16.4% | -13.1% | · | -21.3% | -18.5% | -19.2% | · | -16.0% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $451M | $183M | $17M | $26M | $57M |
| Margen Operativo % | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% |
| Beneficio neto | $-66M | $-116M | $-136M | $-62M | $-14M |
| EPS Diluido | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 0.2 | 0.3 | 0.2 | 0.1 | · |
| Ratio corriente | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 |
| Ratio Rápido | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-22M | $-85M | $-119M | $-50M | $3M |
Propietarios institucionales (13F) 276 declarantes · $3.2B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
276
Valor en tenencia
$3.2B
Nuevas posiciones
37
Posiciones cerradas
33
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 37 (-20 vs trimestre anterior) | 33 (+2 vs trimestre anterior) | 104 (+14 vs trimestre anterior) | 85 (+9 vs trimestre anterior) | -286K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $242 705 264 | 3 856 137 | 7,67% | Acciones |
| Deep Track Capital, LP | $230 786 378 | 3 666 768 | 7,30% | Acciones |
| RTW INVESTMENTS, LP | $211 293 293 | 3 357 059 | 6,68% | Acciones |
| VANGUARD GROUP INC | $196 475 972 | 2 399 560 | 6,21% | Acciones |
| Paradigm Biocapital Advisors LP | $174 699 348 | 2 775 649 | 5,52% | Acciones |
| JANUS HENDERSON GROUP PLC | $157 222 823 | 2 240 963 | 4,97% | Acciones |
| MORGAN STANLEY | $114 996 594 | 1 827 082 | 3,64% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $112 855 448 | 1 793 064 | 3,57% | Acciones |
| JENNISON ASSOCIATES LLC | $104 710 448 | 1 663 655 | 3,31% | Acciones |
| TANG CAPITAL MANAGEMENT LLC | $98 706 662 | 1 568 266 | 3,12% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $89 823 185 | 1 427 124 | 2,84% | Acciones |
| BANK OF AMERICA CORP /DE/ | $75 098 874 | 1 193 182 | 2,37% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $69 605 544 | 1 105 689 | 2,20% | Acciones |
| STATE STREET CORP | $67 531 536 | 1 072 951 | 2,13% | Acciones |
| Vestal Point Capital, LP | $66 087 000 | 1 050 000 | 2,09% | Acciones |
| Assenagon Asset Management S.A. | $59 635 335 | 947 495 | 1,89% | Acciones |
| Invesco Ltd. | $49 458 755 | 785 808 | 1,56% | Acciones |
| GOLDMAN SACHS GROUP INC | $46 745 097 | 742 693 | 1,48% | Acciones |
| Frazier Life Sciences Management, L.P. | $45 860 853 | 728 644 | 1,45% | Acciones |
| D. E. Shaw & Co., Inc. | $44 722 583 | 710 559 | 1,41% | Acciones |
| FMR LLC | $42 355 422 | 672 949 | 1,34% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $38 222 000 | 607 272 | 1,21% | Acciones |
| Clearbridge Investments, LLC | $34 578 420 | 549 387 | 1,09% | Acciones |
| TORONTO DOMINION BANK | $32 115 324 | 510 253 | 1,02% | Acciones |
| TimesSquare Capital Management, LLC | $27 259 589 | 388 590 | 0,86% | Acciones |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $26 875 883 | 427 008 | 0,85% | Acciones |
| Caption Management, LLC | $25 805 400 | 410 000 | 0,82% | Opción de venta |
| NORTHERN TRUST CORP | $24 333 296 | 386 611 | 0,77% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $24 240 523 | 385 137 | 0,77% | Acciones |
| LOOMIS SAYLES & CO L P | $23 960 251 | 380 684 | 0,76% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $21 137 392 | 335 834 | 0,67% | Acciones |
| Tri Locum Partners LP | $20 665 720 | 328 340 | 0,65% | Acciones |
| MPM BIOIMPACT LLC | $20 267 121 | 322 007 | 0,64% | Acciones |
| Driehaus Capital Management LLC | $19 988 233 | 317 576 | 0,63% | Acciones |
| Squarepoint Ops LLC | $18 619 163 | 295 824 | 0,59% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $18 019 030 | 286 289 | 0,57% | Acciones |
| FRANKLIN RESOURCES INC | $18 001 343 | 286 008 | 0,57% | Acciones |
| Artisan Partners Limited Partnership | $17 931 543 | 284 899 | 0,57% | Acciones |
| Rock Springs Capital Management LP | $17 439 856 | 277 087 | 0,55% | Acciones |
| Ensign Peak Advisors, Inc | $16 911 726 | 268 696 | 0,53% | Acciones |
| CITADEL ADVISORS LLC | $15 214 927 | 241 737 | 0,48% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $12 690 215 | 201 624 | 0,40% | Acciones |
| MACKENZIE FINANCIAL CORP | $12 048 478 | 191 428 | 0,38% | Acciones |
| JANE STREET GROUP, LLC | $11 964 894 | 190 100 | 0,38% | Opción de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11 864 190 | 188 500 | 0,38% | Opción de compra |
| Cutter Capital Management, LP | $10 530 850 | 205 000 | 0,33% | Acciones |
| Parkman Healthcare Partners LLC | $9 441 000 | 150 000 | 0,30% | Acciones |
| JPMORGAN CHASE & CO | $8 683 850 | 139 981 | 0,27% | Acciones |
| Allspring Global Investments Holdings, LLC | $7 935 733 | 130 329 | 0,25% | Acciones |
| Seven Fleet Capital Management LP | $7 909 873 | 117 067 | 0,25% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Horowitz Limited Partnership VIII, Horowitz Management, Inc., Adam S. Horowitz Revocable Trust, Jason E. Tester | 30 de octubre de 2020 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 21 insiders · 10 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Bobak R. Azamian | President/CEO and Board Chair | 4 de septiembre de 2026 S | 827 991 | 0 | 10 | $-5 181 683 |
| Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | 15 de junio de 2026 M | 56 801 | 0 | 4 | $-1 317 002 |
| Leonard M. Greenstein | Chief Financial Officer | 20 de abril de 2023 S | 26 785 | 0 | 0 | $0 |
| Seshadri Neervannan | Chief Operating Officer | 4 de septiembre de 2026 S | 78 532 | 0 | 6 | $-2 001 321 |
| Elizabeth Yeu Lin | Chief Medical Officer | 4 de septiembre de 2026 S | 1 590 | 0 | 11 | $-2 362 279 |
| Bryan Wahl | General Counsel | 19 de marzo de 2026 S | 63 959 | 0 | 3 | $-850 417 |
| Dianne C. Whitfield | Chief Human Resources Officer | 19 de marzo de 2026 S | 35 028 | 0 | 8 | $-2 687 252 |
| Aziz Mottiwala | Chief Commercial Officer | 19 de marzo de 2026 S | 61 480 | 0 | 3 | $-892 528 |
| Jose M. Trevejo | CHIEF MEDICAL OFFICER | 20 de diciembre de 2023 S | 2 251 | 0 | 0 | $0 |
| Mark J. Holdbrook | V.P., Clinical Affairs | 20 de marzo de 2023 S | 3 191 | 0 | 0 | $0 |
| William J Link PHD | Consejero | 15 de septiembre de 2026 M | 94 487 | 0 | 13 | $-4 480 738 |
| Wendy L Yarno | Consejero | 15 de septiembre de 2026 M | 16 956 | 0 | 0 | $0 |
| David E I Pyott | Consejero | 15 de septiembre de 2026 M | 9 575 | 0 | 0 | $0 |
| Katherine Goodrich | Consejero | 25 de junio de 2026 A | 2 233 | 0 | 1 | $-183 384 |
| Andrew D. Goldberg | Consejero | 25 de junio de 2026 A | 19 654 | 0 | 0 | $0 |
| Scott W Morrison | Consejero | 25 de junio de 2026 A | 7 638 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Consejero | 25 de junio de 2026 A | 11 654 | 0 | 0 | $0 |
| Rosemary A Crane | Consejero | 24 de junio de 2024 M | 5 350 | 0 | 0 | $0 |
| Michael Ackermann | Consejero | 16 de junio de 2022 A | 1 208 273 | 0 | 0 | $0 |
| Jason E. Tester | Consejero | 15 de junio de 2021 A | 1 920 933 | 0 | 0 | $0 |
| Horowitz Limited Partnership VIII | Propietario del 10% | 20 de octubre de 2020 C | 66 172 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 36 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 3,53% | 250 245 SH | 1 de octubre de 2026 | Diario |
| BBP · ETFis Series Trust I | 1,31% | 21 906 NS | 31 de julio de 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,10% | 3 832 NS | 31 de julio de 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,03% | 29 628 NS | 31 de julio de 2026 | N-PORT |
| IHE · iShares Trust | 0,73% | 146 508 SH | 11 de septiembre de 2026 | Diario |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,25% | 55 774 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,24% | 308 150 SH | 11 de septiembre de 2026 | Diario |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,24% | 3 264 SH | 1 de octubre de 2026 | Diario |
| IWO · iShares Trust | 0,22% | 392 987 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,16% | 44 912 SH | 19 de agosto de 2026 | Diario |
| ESSC · Strategy Shares | 0,16% | 952 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,11% | 1 070 015 SH | 11 de septiembre de 2026 | Diario |
| ISCG · iShares Trust | 0,10% | 12 082 SH | 11 de septiembre de 2026 | Diario |
| FSMD · FIDELITY COVINGTON TRUST | 0,10% | 42 141 NS | 31 de julio de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,09% | 1 364 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 10 366 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,08% | 241 028 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,08% | 20 052 NS | 31 de julio de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 13 860 NS | 31 de julio de 2026 | N-PORT |
| ESML · iShares Trust | 0,06% | 19 942 SH | 11 de septiembre de 2026 | Diario |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,05% | 5 052 NS | 31 de julio de 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 1 556 SH | 1 de octubre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 455 389 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,03% | 89 651 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 9 191 SH | 1 de octubre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 14 156 NS | 31 de julio de 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 1 911 SH | 11 de septiembre de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,02% | 6 187 SH | 19 de agosto de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 54 976 SH | 11 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,00% | 1 580 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 9 991 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 295 901 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3 359 SH | 19 de agosto de 2026 | Diario |
| ISCB · iShares Trust | · | 1 731 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 66 526 SH | 11 de septiembre de 2026 | Diario |
| SMMV · iShares Trust | · | 1 979 SH | 1 de septiembre de 2026 | Diario |
TARS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$100.00
+37,0%
7 50,0%
Compra fuerte
6 42,9%
Compra
1 7,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
10 analistas · 2026-09-30Objetivo medio $99.50 +36,3%
← Por Debajo de Todos los Objetivos
Precio Actual $73.00
Mín$84.00
Media$99.50
Máx$116.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | · |
| INDV | · | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| AMLX | $1.33B | -7.9 | -77.1% | · | -61.2% | · |
| ELVN | $915M | -8.4 | · | · | -21.9% | · |
| MBX | $1.42B | -13.3 | · | · | -29.6% | · |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | · |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | · |
| AMRX | · | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026